(TLS) Telos - Overview
Stock: Cyber Compliance, Secure Networks, Identity Platform, Biometric Sdk, PreCheck
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 88.6% |
| Relative Tail Risk | -18.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 26.70 |
| Character TTM | |
|---|---|
| Beta | 1.703 |
| Beta Downside | 1.311 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.75% |
| CAGR/Max DD | 0.06 |
Description: TLS Telos December 31, 2025
Telos Corporation (NASDAQ:TLS) delivers cyber, cloud, and enterprise-security solutions to U.S. federal agencies, large enterprises, state and local governments, and international customers, operating through two segments: Security Solutions and Secure Networks.
Its flagship offerings include the Xacta platform for automated cyber-risk management and compliance, the IDTrust360 identity-risk service for hybrid-cloud environments, and the ONYX SDK that turns standard smartphone cameras into touchless fingerprint authenticators. Complementary services span consulting, penetration testing, network-defense operations, and the Telos Automated Message Handling System used for mission-critical military communications.
Key macro drivers for Telos are sustained federal IT budget growth (FY24 defense IT spending is projected to rise ~5% YoY) and the broader corporate shift toward zero-trust and hybrid-cloud security, which the IDC estimates will boost global cyber-security spend to $185 billion in 2025, outpacing overall IT growth.
According to the company’s FY 2023 Form 10-K, Telos generated roughly $260 million in revenue, a 10% year-over-year increase, with an operating margin of ~12% and a contract backlog exceeding $1.2 billion-providing visibility into future cash flows. R&D intensity remains around 13% of revenue, reflecting ongoing investment in AI-enabled security automation.
For a deeper, data-driven assessment of Telos’s valuation and risk profile, you may find the analyst tools on ValueRay worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -29.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 13.47 > 1.0 |
| NWC/Revenue: 45.40% < 20% (prev 58.58%; Δ -13.18% < -1%) |
| CFO/TA 0.07 > 3% & CFO 11.7m > Net Income -29.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (72.8m) vs 12m ago 0.71% < -2% |
| Gross Margin: 38.28% > 18% (prev 0.34%; Δ 3794 % > 0.5%) |
| Asset Turnover: 87.35% > 50% (prev 73.93%; Δ 13.43% > 0%) |
| Interest Coverage Ratio: -24.63 > 6 (EBITDA TTM -20.3m / Interest Expense TTM 1.15m) |
Altman Z'' -13.61
| A: 0.40 (Total Current Assets 102.8m - Total Current Liabilities 37.3m) / Total Assets 164.3m |
| B: -2.12 (Retained Earnings -347.6m / Total Assets 164.3m) |
| C: -0.17 (EBIT TTM -28.4m / Avg Total Assets 165.3m) |
| D: -7.79 (Book Value of Equity -347.5m / Total Liabilities 44.6m) |
| Altman-Z'' Score: -13.61 = D |
Beneish M -3.16
| DSRI: 1.17 (Receivables 20.4m/14.9m, Revenue 144.4m/123.0m) |
| GMI: 0.89 (GM 38.28% / 34.13%) |
| AQI: 0.94 (AQ_t 0.32 / AQ_t-1 0.34) |
| SGI: 1.17 (Revenue 144.4m / 123.0m) |
| TATA: -0.25 (NI -29.6m - CFO 11.7m) / TA 164.3m) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of TLS shares?
Over the past week, the price has changed by -10.44%, over one month by -7.56%, over three months by -25.46% and over the past year by +51.86%.
Is TLS a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TLS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.7 | 77.9% |
| Analysts Target Price | 8.7 | 77.9% |
| ValueRay Target Price | 5.1 | 4.9% |
TLS Fundamental Data Overview February 02, 2026
P/B = 3.3649
Revenue TTM = 144.4m USD
EBIT TTM = -28.4m USD
EBITDA TTM = -20.3m USD
Long Term Debt = 8.60m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 2.09m USD (from shortTermDebt, last fiscal year)
Debt = 6.38m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -52.7m USD (from netDebt column, last quarter)
Enterprise Value = 350.0m USD (402.7m + Debt 6.38m - CCE 59.0m)
Interest Coverage Ratio = -24.63 (Ebit TTM -28.4m / Interest Expense TTM 1.15m)
EV/FCF = 75.96x (Enterprise Value 350.0m / FCF TTM 4.61m)
FCF Yield = 1.32% (FCF TTM 4.61m / Enterprise Value 350.0m)
FCF Margin = 3.19% (FCF TTM 4.61m / Revenue TTM 144.4m)
Net Margin = -20.47% (Net Income TTM -29.6m / Revenue TTM 144.4m)
Gross Margin = 38.28% ((Revenue TTM 144.4m - Cost of Revenue TTM 89.1m) / Revenue TTM)
Gross Margin QoQ = 39.94% (prev 33.17%)
Tobins Q-Ratio = 2.13 (Enterprise Value 350.0m / Total Assets 164.3m)
Interest Expense / Debt = 11.16% (Interest Expense 712.0k / Debt 6.38m)
Taxrate = 21.0% (US default 21%)
NOPAT = -22.4m (EBIT -28.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.76 (Total Current Assets 102.8m / Total Current Liabilities 37.3m)
Debt / Equity = 0.05 (Debt 6.38m / totalStockholderEquity, last quarter 119.7m)
Debt / EBITDA = 2.59 (negative EBITDA) (Net Debt -52.7m / EBITDA -20.3m)
Debt / FCF = -11.43 (Net Debt -52.7m / FCF TTM 4.61m)
Total Stockholder Equity = 122.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -17.89% (Net Income -29.6m / Total Assets 164.3m)
RoE = -24.07% (Net Income TTM -29.6m / Total Stockholder Equity 122.8m)
RoCE = -21.59% (EBIT -28.4m / Capital Employed (Equity 122.8m + L.T.Debt 8.60m))
RoIC = -18.25% (negative operating profit) (NOPAT -22.4m / Invested Capital 122.8m)
WACC = 12.14% (E(402.7m)/V(409.1m) * Re(12.19%) + D(6.38m)/V(409.1m) * Rd(11.16%) * (1-Tc(0.21)))
Discount Rate = 12.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.12%
[DCF Debug] Terminal Value 54.15% ; FCFF base≈4.61m ; Y1≈3.02m ; Y5≈1.38m
Fair Price DCF = 0.93 (EV 16.0m - Net Debt -52.7m = Equity 68.7m / Shares 73.8m; r=12.14% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -37.67 | EPS CAGR: -5.21% | SUE: 1.29 | # QB: 1
Revenue Correlation: -62.53 | Revenue CAGR: -5.68% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.01 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=0.10 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+81.0% | Growth Revenue=+19.7%